The Second National Clinical Conference on Cannabis Therapeutics May 3&4, 2002

The Second National Clinical Conference on Cannabis Therapeutics will be held in Portland, Oregon
on May 3&4, 2002.
Click here for conference agenda:
Click here for conference brochure:

General Information

All conference activities will be held at the Holiday Inn, Portland-Convention Center, 1021 NE Grand Ave., Portland, OR 97232

Air Travel: From the Portland International Airport take the “MAX Redline” light-rail from outside the baggage claim to the Oregon Convention Center stop which is across the street from the Holiday Inn. You will be reimbursed for the fare, $1.55, and given a return pass upon check-in. The train runs four times per hour.

Lodging: A group rate price of $89.00 per night, double, plus tax (about $11) is available through March 30, 2002 at the Holiday Inn at the Convention Center. All rooms have coffee makers, refrigerators, cable, workstations including data ports and fitness center privileges. Please indicate that you are attending the medical marijuana conference. Rates may increase after that date. Attendees are responsible for arranging their own overnight accommodations.

Parking: Available to overnight guests at $6.00 per day plus street parking.

Registration: Advance conference registration is requested. Limited seating. Full conference registration fees include all program materials, an opening reception, two continental breakfasts, one lunch and all breaks. On site registration will be available space permitting. Cancellations prior to the conference opening will be refunded in full less a $15 handling fee. No refunds after April 22, 2002. Registration must be accompanied by check, money order, Visa or MasterCard. Purchase orders cannot be accepted.

The Planning Committee reserves the right to change the program, or to cancel the conference due to insufficient enrollment. Please call (503) 731-6633 regarding refunds or cancellations.

Benefit Dinner for Patients Out of Time: All proceeds from the Friday evening dinner will be used by Patients Out of Time for the purpose of educating health care professionals, patients and the public about therapeutic Cannabis. Patients Out of Time is a volunteer non-profit organization that spends 100% of donated funds on its educational mission. A portion of the dinner donation is tax deductible.

Continuing Education Units: The CEU has been designed to give recognition to persons continuing their education in their chosen field or profession. The 1.2 CEU’s for this conference are provided under the authority of the Portland Community College Institute of Health Professionals.

Further information and press contacts should call Al Byrne at (434) 263-4484 or al@medicalcannabis.com. Information and registration forms are available at conference@medicalcannabis.com. Registration questions should be directed to (503) 731-6633. Registration forms may be faxed to (503) 731-6632.

Statement of Purpose

The purpose of this conference series, including the Portland, Oregon forum, is to resurrect the knowledge base of therapeutic Cannabis in public, accredited venues that are directed to clinical application. No academic medical education concerning therapeutic Cannabis has been provided to any MD or RN in the United States since 1938. The “corporate knowledge” of the health care community on this subject is gone. These conferences bring replicated, science based research to clinicians, patients, the press and the public upon which individuals can make informed decisions about therapeutic Cannabis use.

Portland Faculty

-Donald Abrams, MD: University of California, San Francisco
-Michael Aldrich, PhD: Director, Californians Helping Alleviate Medical Problems, San Francisco
-David Bearman, MD: Medical Services, Santa Barbara, CA
-Hilary Black: Founder, Compassion Club, Vancouver, B.C.
-Sandee Burbank: Founder, Mothers Against Misuse and Abuse, Mosier, OR
-Sumner Burstein, PhD: University of Massachusetts, Worcester
-Allan Byrne, Lcdr., USN, (ret): Co-founder, Patients Out of Time, Howardsville, VA
-Robert Clarke, BS: Director, Pharmtex Consultants, San Diego, CA
-Valerie Corral: Founder, Wo/Men’s Alliance for Medical Marijuana, Santa Cruz, CA
-Todd Dalotto: Director, Compassion Center, Eugene, OR
-Edward Glick, RN: Founder, Contigo-Conmigo, Monmouth, OR
-Geoffrey Guy, MD: Founder, GW Pharmaceuticals, Dorset, UK
-Grant Higginson, MD: Oregon State Health Officer, Portland
-Scott Imler: President, Los Angeles Cannabis Resource Center, Hollywood
-Teresa Keane, RN, MSN, PMHNP: Director, Stress Reduction Program, Legacy Emmanuel Hospital, Portland, OR
-Gail Kelsey, BS: Administrator, Colorado Medical Marijuana Registry Program
-Pamela Lichty, BA, MPH: University of Hawaii, Honolulu
-Madeline Martinez: OMMA Patient, Portland
-Mary Lynn Mathre, RN, MSN, CARN: University of Virginia, Charlottesville
-George McMahon: Director, Patients Out of Time, Frankston, TX
-Raphael Mechoulam, PhD: The Hebrew University of Jerusalem
-Elvy Musikka: Patients Out of Time, Orangevale, CA
-Richard Musty, PhD: University of Vermont, Middlebury
-Stuart Rosenblum MD: Director, Pain Clinic, Legacy Emmanuel Hospital, Portland, OR
-Irvin Rosenfeld: Patients Out of Time, Lauderhill, FL
-Ethan Russo, MD: Editor, Journal of Cannabis Therapeutics, Missoula, MT
-Juan Sanchez-Ramos, MD: University of South Florida, Tampa
-Audra Stinchcomb, PhD: University of Kentucky, Lexington
-Donald Topping, PhD: Governor’s Substance Abuse Task Force, Honolulu, HI
-Mark Ware, MD: Health Canada Cannabis Pain Study, Quebec
-Donald Wirtshafter, JD: Founder, Ohio Hempery, Guysville